People channel feed

No­var­tis' San­doz chief is walk­ing out in the mid­dle of a glob­al re­vamp, fu­el­ing fresh buzz about a spin­off

7 years ago

Em­ma Walm­s­ley earns £1M pay rise in her first full year at GSK's helm — but £5.9M pack­age still trails oth­er Big Phar­ma CEOs

7 years ago

End­points News poll: In­dus­try in­sid­ers of­fer a big 👍 for Ned Sharp­less

7 years ago
Pharma

NCI's Ned Sharp­less gets the nod to run the FDA in wake of Scott Got­tlieb’s sur­prise ex­it

7 years ago
Pharma

Two big phar­ma ex­ecs share the same chal­lenges, but com­pen­sa­tion? They’re not even close

7 years ago

Prison of­fi­cials launch a probe in­to Mar­tin Shkre­li's lat­est an­tics, al­leged­ly run­ning his biotech busi­ness with a con­tra­band cell phone

7 years ago

The Fort Dix re­demp­tion: Mar­tin Shkre­li’s con­tra­band cell phones, new biotech schemes and fresh so­cial me­dia in­famy

7 years ago

From din­ner in Mu­nich to $5.85 a share, Im­mune De­sign ex­ecs pushed for every pen­ny they could get from the Mer­ck bar­gain buy­out

7 years ago
Deals

On­col­o­gy pipeline chief Alessan­dro Ri­va joins the ex­o­dus at Gilead, head­ing to helm a biotech spin­off 4 days af­ter O'­Day's ar­rival as CEO

7 years ago

Pop­u­lar FDA com­mish Scott Got­tlieb has hand­ed in his res­ig­na­tion

7 years ago
Pharma

Was As­traZeneca CEO Pas­cal So­ri­ot hap­py with his $14.8M in '18 com­pen­sa­tion? Prob­a­bly not so much

7 years ago

Bad year at Cel­gene? For­get about it. CEO Mark Alles nabbed a big raise as com­pen­sa­tion gy­rat­ed to $16.2M

7 years ago

Build­ing on mo­men­tum from pos­i­tive di­a­betes da­ta, Zaf­gen scoops Bio­gen alum Priya Sing­hal as head of R&D

7 years ago

Ea­ger to think big­ger than Chi­na, As­cle­tis woos top Mer­ck ex­ec to run R&D

7 years ago

Parex­el re­cruits top FDA on­col­o­gy ex­pert Amy Mc­K­ee for new R&D ini­tia­tive

7 years ago
Pharma

Im­munomedics CEO Michael Pehl hits the ex­it on the heels of a CRL and ac­cu­sa­tions of a da­ta in­tegri­ty breach

7 years ago

Ra­maswamy's rare-dis­ease off­shoot En­zy­vant poach­es Alex­ion ex­ec Rachelle Jacques to re­place Alvin Shih at the helm

7 years ago

Ex-Cel­gene CEO Bob Hug­in makes a leap back in­to biotech, join­ing an em­bat­tled Al­ler­gan's board

7 years ago

David de Graaf has a new gig, a new idea and a new start­up — hunt­ing some new mon­ey

7 years ago
Startups

Vas Narasimhan earned a big pay hike when he moved to the CEO's suite at No­var­tis

7 years ago

As dig­i­tal med­i­cine ex­plodes in the zeit­geist of health­care, Sanofi fol­lows peers in ap­point­ing chief dig­i­tal of­fi­cer

7 years ago

Af­ter a short stint at In­ter­cept, Rachel McMinn makes the leap from biotech an­a­lyst to biotech CEO

7 years ago
Financing
Startups

David Schenkein gets his third act in biotech, join­ing Google's GV to co-lead life sci­ences group

7 years ago

As­traZeneca CEO So­ri­ot is over­see­ing a top ex­ec team over­haul in move to in­te­grate Med­Im­mune in a sweep­ing re­struc­tur­ing

7 years ago
First page Previous page 81828384858687 Next page Last page
A service from the Financial Times